Suppr超能文献

蛋白酶体通道最终关卡的守护者:调节复合物与通道门控

Keepers at the final gates: regulatory complexes and gating of the proteasome channel.

作者信息

Bajorek M, Glickman M H

机构信息

Department of Biology and the Institute for Catalysis Science and Technology, Technion -- Israel Institute of Technology, Haifa, Israel.

出版信息

Cell Mol Life Sci. 2004 Jul;61(13):1579-88. doi: 10.1007/s00018-004-4131-y.

Abstract

The proteolytic active sites of the 26S proteasome are sequestered within the central chamber of its 20S catalytic core particle. Access to this chamber is through a narrow channel defined by the outer alpha subunits. Free proteasome 20S core particles are found in an autoinhibited state in which the N-termini of neighboring alpha subunits are anchored by an intricate lattice of interactions blocking access to the channel. Entry of substrates into proteasomes can be enhanced by attachment of activators or regulatory particles. An important part of this activation is channel gating; regulatory particles rearrange the blocking residues to form an open pore and promote substrate entry into the proteolytic chamber. Interestingly, some substrates can open the entrance themselves and thus facilitate their own destruction. In this review, we will discuss the mechanisms proposed for channel gating and the interactions required to maintain stable closed and open conformations.

摘要

26S蛋白酶体的蛋白水解活性位点被隔离在其20S催化核心颗粒的中央腔室内。进入该腔室需通过由外部α亚基界定的狭窄通道。游离的20S核心颗粒处于自抑制状态,相邻α亚基的N端通过复杂的相互作用晶格锚定,从而阻断通道入口。通过附着激活剂或调节颗粒可增强底物进入蛋白酶体的过程。这种激活的一个重要部分是通道门控;调节颗粒重新排列阻断残基以形成开放孔,并促进底物进入蛋白水解腔室。有趣的是,一些底物自身可以打开入口,从而促进自身的降解。在本综述中,我们将讨论提出的通道门控机制以及维持稳定的闭合和开放构象所需的相互作用。

相似文献

1
Keepers at the final gates: regulatory complexes and gating of the proteasome channel.
Cell Mol Life Sci. 2004 Jul;61(13):1579-88. doi: 10.1007/s00018-004-4131-y.
2
Structure and assembly of the 20S proteasome.
Cell Mol Life Sci. 1998 Mar;54(3):253-62. doi: 10.1007/s000180050147.
3
A gated channel into the proteasome core particle.
Nat Struct Biol. 2000 Nov;7(11):1062-7. doi: 10.1038/80992.
4
Proteasome disassembly and downregulation is correlated with viability during stationary phase.
Curr Biol. 2003 Jul 1;13(13):1140-4. doi: 10.1016/s0960-9822(03)00417-2.
5
Structure and functions of the 20S and 26S proteasomes.
Annu Rev Biochem. 1996;65:801-47. doi: 10.1146/annurev.bi.65.070196.004101.
6
The ultimate nanoscale mincer: assembly, structure and active sites of the 20S proteasome core.
Cell Mol Life Sci. 2004 Jul;61(13):1562-78. doi: 10.1007/s00018-004-4130-z.
7
Subunit arrangement in the human 20S proteasome.
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2939-44. doi: 10.1073/pnas.94.7.2939.
8
The regulatory particle of the Saccharomyces cerevisiae proteasome.
Mol Cell Biol. 1998 Jun;18(6):3149-62. doi: 10.1128/MCB.18.6.3149.
9
Structural basis for the activation of 20S proteasomes by 11S regulators.
Nature. 2000 Nov 2;408(6808):115-20. doi: 10.1038/35040607.
10
Substrate access and processing by the 20S proteasome core particle.
Int J Biochem Cell Biol. 2003 May;35(5):606-16. doi: 10.1016/s1357-2725(02)00390-4.

引用本文的文献

2
Proteasome Activators and Ageing: Restoring Proteostasis Using Small Molecules.
Subcell Biochem. 2024;107:21-41. doi: 10.1007/978-3-031-66768-8_2.
3
A Role for the Proteasome Alpha2 Subunit N-Tail in Substrate Processing.
Biomolecules. 2023 Mar 5;13(3):480. doi: 10.3390/biom13030480.
6
Structural Insights into Substrate Recognition and Processing by the 20S Proteasome.
Biomolecules. 2021 Jan 24;11(2):148. doi: 10.3390/biom11020148.
7
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
Pharmacol Ther. 2020 Sep;213:107579. doi: 10.1016/j.pharmthera.2020.107579. Epub 2020 May 19.
8
Cryo-EM structures of the human PA200 and PA200-20S complex reveal regulation of proteasome gate opening and two PA200 apertures.
PLoS Biol. 2020 Mar 5;18(3):e3000654. doi: 10.1371/journal.pbio.3000654. eCollection 2020 Mar.
9
Probing the cooperativity of proteasome core particle gating by NMR spectroscopy.
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9846-E9854. doi: 10.1073/pnas.1712297114. Epub 2017 Oct 30.

本文引用的文献

1
Medical and obstetric complications among pregnant women aged 45 and older.
PLoS One. 2014 Apr 25;9(4):e96237. doi: 10.1371/journal.pone.0096237. eCollection 2014.
4
Cardiovascular diseases in pregnancy.
Dtsch Arztebl Int. 2011 Apr;108(16):267-73. doi: 10.3238/arztebl.2011.0267. Epub 2011 Apr 22.
5
Technique of interventional repair in adult aortic coarctation.
J Vasc Surg. 2010 Jun;51(6):1550-9. doi: 10.1016/j.jvs.2009.12.063. Epub 2010 Mar 11.
6
The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care.
Dtsch Arztebl Int. 2009 Nov;106(45):733-8. doi: 10.3238/artebl.2009.0733. Epub 2009 Nov 6.
7
[Congenital heart disease. Transition from adolescence to adulthood].
Internist (Berl). 2009 Oct;50(10):1221-2, 1224-7. doi: 10.1007/s00108-009-2400-4.
9
Postpartum cardiomyopathy: a cardiac emergency for gynecologists, general practitioners, internists, pulmonologists, and cardiologists.
Dtsch Arztebl Int. 2008 Oct;105(44):751-6. doi: 10.3238/arztebl.2008.0751. Epub 2008 Oct 31.
10
Spontaneous coronary artery dissection: case series and review.
J Invasive Cardiol. 2008 Oct;20(10):553-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验